Breakthrough vaccine for the deadliest skin cancer cut risk by almost half

The skin cancer vaccine is based on mRNA technology that helped end the coronavirus pandemic.

Moderna and Merck say their mRNA cancer vaccine cut death, recurrence by 42%

Personalized mRNA vaccines against melanoma—the deadliest form of skin cancer—reduced the risk of death or recurrence by 42 ...
Hosted on MSN

A personalized vaccine for melanoma cut the risk of cancer returning after five years

An experimental vaccine from Moderna shows promise in keeping deadly skin cancer from returning for years, according to new clinical trial results. The research, presented Monday at the American ...

Cancer Vaccine Cuts the Risk of Melanoma Recurrence, Drug Makers Report

A first-of-its-kind vaccine against cancer may be on the horizon.
Reuters

Moderna, Merck vaccine cuts recurrence and spread of melanoma, raising new treatment hope

Interim analysis shows goals were met for recurrence and preventing cancer spread Moderna spikes as much as 160%; Merck jumps 12% Barclays estimates therapy could reach about $3 billion in melanoma ...